scorecardresearch
Business Today
Subscribe
Immersives UPSTART ICC World Cup Corporate Petrol-Diesel Weather BT Bazaar
BT Golf BT 500 Zero Mile Samvad - IIM Nagpur BT-TR GCC Listing
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
  • BT tech today
  • BT 500 wealth creators summit
  • zero mile samvad iim nagpur
News
Markets
Stocks
Ajanta Pharma Ltd

Feedback
Ajanta Pharma Ltd

Ajanta Pharma Ltd (AJANTPHARM) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 9,425
Dec 15, 2023 09:58 IST-
  • NSE
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹1,888.65
₹9.65 (0.51%)
₹1873.55 Low
Today’s Performance
₹1892.75 High
₹1131.7 Low
52 Week’s Performance
₹2067.4 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day 0.51%
  • 1 Week -4.06%
  • 1 Month -3.61%
  • 3 Months 4.79%
  • 6 Months 27.33%
  • 1 Year 55.86%
  • 3 Years 18.80%
  • 5 Years 20.73%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 2.00
  • Beta 0.18
  • 52-Week Low (₹) 1,131.70
  • 52-Week High (₹) 2,067.40
  • Price-to-Book (X)* 6.81
  • Dividend Yield (%) 0.37
  • Price-to-Earnings (P/E) (X)* 35.92
  • Earnings Per Share (₹) 52.43
  • Sector Price Earning (X)* 32.73
  • Market Cap (₹ Cr.)* 23,659.74
  • * Vaues as of last close price

COMPETITORS

BT TV

thumb 1:59 Sudeep Shah From SBI Securities Identifies Two Stocks Poised For Strong Upside Movement!
thumb 3:29 Shri Krishna Janmabhoomi Case: High Court Approves Survey Of Shahi Idgah Complex
thumb 2:07 Listen To SMIFS' Sharad Avasthi's Call On DOMS & India Shelter Finance IPOs Ending On Friday
thumb 2:09 Electrifying Delhi's Commute: Delhi's Got More Electric Buses! Hop On Board For A Greener Commute!
thumb 3:59 Derek O'Brien Suspended After Face-off With RS Chairman! MP Charged With "Ignoble Misconduct"
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

Dec 22, 2022 Sell
Ajanta Pharma Lt ,AAYUSH AGRAWAL TRUST
  • Qty 3853959
  • Average Price ₹1,160.10
Dec 22, 2022 Sell
Ajanta Pharma Lt ,RAVI AGRAWAL TRUST
  • Qty 1638887
  • Average Price ₹1,160.10
Dec 22, 2022 PURCHASE
Ajanta Pharma Lt ,TEACHERS' RETIREMENT SYSTEM OF THE STATE OF ILLINOIS ?¿ GRANDEUR PEAK GLOBAL ADVISORS
  • Qty 72121
  • Average Price ₹1,160.10
Dec 22, 2022 PURCHASE
Ajanta Pharma Lt ,TATA AIA LIFE INSURANCE COMPANY LIMITED
  • Qty 323240
  • Average Price ₹1,160.10
Dec 22, 2022 PURCHASE
Ajanta Pharma Lt ,NIPPON INDIA MUTUAL FUND
  • Qty 715450
  • Average Price ₹1,160.10
Dec 22, 2022 PURCHASE
Ajanta Pharma Lt ,MIRAE ASSET MUTUAL FUND
  • Qty 129300
  • Average Price ₹1,160.10
Dec 22, 2022 PURCHASE
Ajanta Pharma Lt ,INDIA ACORN FUND LTD
  • Qty 20776
  • Average Price ₹1,160.10
Dec 22, 2022 PURCHASE
Ajanta Pharma Lt ,ICICI PRUDENTIAL MUTUAL FUND
  • Qty 1086110
  • Average Price ₹1,160.10
Dec 22, 2022 PURCHASE
Ajanta Pharma Lt ,GRANDEUR PEAK INTERNATIONAL STALWARTS L.P.
  • Qty 63325
  • Average Price ₹1,160.10
Dec 22, 2022 PURCHASE
Ajanta Pharma Lt ,GRANDEUR PEAK INTERNATIONAL STALWARTS FUND
  • Qty 441844
  • Average Price ₹1,160.10
*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.
Dec 22, 2022 Sell
Ajanta Pharma Ltd ,RAVI AGRAWAL TRUST
  • Qty 1638887
  • Average Price ₹1,160.10
Dec 22, 2022 Sell
Ajanta Pharma Ltd ,AAYUSH AGRAWAL TRUST
  • Qty 3853959
  • Average Price ₹1,160.10
Dec 22, 2022 PURCHASE
Ajanta Pharma Ltd ,NIPPON INDIA MUTUAL FUND
  • Qty 715450
  • Average Price ₹1,160.10
Dec 22, 2022 PURCHASE
Ajanta Pharma Ltd ,ICICI PRUDENTIAL MUTUAL FUND
  • Qty 1086110
  • Average Price ₹1,160.10
*Involves transaction of at least 0.5% of the listed shares of a company.

FAQ’S

What was Ajanta Pharma Ltd share price previously?
Ajanta Pharma Ltd share price was up by 0.51% from the previous closing price of ₹1,879.00.
Who are peers of Ajanta Pharma Ltd?
The peers of Ajanta Pharma Ltd are Divis Laboratories Ltd, Sun Pharmaceuticals Industries Ltd, Gland Pharma Ltd, Zydus Lifesciences Ltd, Ipca Laboratories Ltd, Aurobindo Pharma Ltd, Dr Reddys Laboratories Ltd, Biocon Ltd, Glaxosmithkline Pharmaceuticals Ltd, Torrent Pharmaceuticals Ltd, Alkem Laboratories Ltd, Cipla Ltd, Lupin Ltd, Syngene International Ltd.
Who is/are the promoter/promoters of Ajanta Pharma Ltd?
The promotor/promotors of Ajanta Pharma Ltd are Mannalal B Agrawal, Madhusudan B Agrawal, Yogesh Agrawal, Chandrakanth M Khetan, Gaurang Shah, Rajesh M Agrawal, K H Viswanathan, Prabhakar Dalal, Anjana Grewal.
What has been 52-week high of Ajanta Pharma Ltd stocks?
The highest price of Ajanta Pharma Ltd stock is ₹2,067.40 in the last 52-week.
What is the share price of Ajanta Pharma Ltd (AJANTPHARM) today on NSE?
As on Dec 15, 2023, Ajanta Pharma Ltd (AJANTPHARM)’s share price on NSE is Rs 1888.65
What is the market cap of Ajanta Pharma Ltd (AJANTPHARM?)
The current market capitalisation of Ajanta Pharma Ltd (AJANTPHARM) is 23,659.74 crores
What is Ajanta Pharma Ltd Share symbol?
The symbol of Ajanta Pharma Ltd is AJANTPHARM.
What is the PE ratio of Ajanta Pharma Ltd (AJANTPHARM)?
The current PE ratio of Ajanta Pharma Ltd (AJANTPHARM) is 35.92.
What is the PB ratio of Ajanta Pharma Ltd (AJANTPHARM)?
The current PB ratio of Ajanta Pharma Ltd (AJANTPHARM) is 6.81.
Today’s High & Low share prices of Ajanta Pharma Ltd (AJANTPHARM) on NSE?
Today, the share price of Ajanta Pharma Ltd (AJANTPHARM) on NSE touched a high of Rs 1892.75 and a low of Rs 1873.55
What price did Ajanta Pharma Ltd (AJANTPHARM) shares open on the NSE today?
On NSE, the share price of Ajanta Pharma Ltd (AJANTPHARM) opened at Rs 1884
What is the 52-week high of Ajanta Pharma Ltd (AJANTPHARM)?
The 52-week high price of Ajanta Pharma Ltd (AJANTPHARM) is Rs 2067.4
What is the 52-week low of Ajanta Pharma Ltd (AJANTPHARM) ?
The 52-week low price of Ajanta Pharma Ltd (AJANTPHARM) is Rs 1131.7

ABOUT AJANTA PHARMA

Ajanta Pharma Ltd, incorporated in the year 1979, has its registered office in Ajanta House, Charkop Kandivli (W), Mumbai, Maharashtra, 400067, 91-22-66061000/1204/1203, 91-22-66061200/1300. The main industry in which Ajanta Pharma Ltd operates is Pharmaceuticals - Indian - Formulations.

Auditor/Auditors for Ajanta Pharma Ltd is/are B S R & Co LLP. In the main management, Mannalal B Agrawal is chairman and Gaurang Shah is the company secretary for Ajanta Pharma Ltd.

  • MBA Mannalal B Agrawal Chairman (Non-Executive)
  • MBA Madhusudan B Agrawal Vice Chairman
  • YA Yogesh Agrawal Managing Director
  • CMK Chandrakanth M Khetan Independent Director
  • GS Gaurang Shah Vice President & CS
  • RMA Rajesh M Agrawal Joint Managing Director
  • KHV K H Viswanathan Independent Director
  • PD Prabhakar Dalal Independent Director
  • AG Anjana Grewal Independent Director

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.

Advertisement